Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
European Heart Journal|April 17, 2018
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Jonathan L Halperin, et al.
Journal of Arrhythmia|August 13, 2021
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the worldMonika Kozieł, Christine Teutsch, Valentina Bayer, et al.
Thrombosis and Haemostasis|June 28, 2016
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillationJohn M Kittelson, Philippe Gabriel Steg, Jonathan L Halperin, et al.
Circulation|July 31, 2015
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and OutcomesWobo Bekwelem, Stuart J Connolly, Jonathan L Halperin, et al.
Plos One|April 14, 2021
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AFMonika Kozieł, Christine Teutsch, Jonathan L Halperin, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|February 23, 2026
Right-Sided Extravalvular Damage: An Overlooked Driver of Risk Model Failure in Low-Flow, Low-Gradient Aortic StenosisYash Prakash, Akarsh Sharma, Lakshay Chopra, et al.
Pageof 21